Brief

Patients using Omega Pharma's products should continue taking their medication as instructed. Those with concerns about their medicine should consult their pharmacist or doctor for advice. Omega Pharma has addressed the infringement notice and inspection findings, implementing corrective actions reviewed during a subsequent MHRA re-inspection of the company. This ensures compliance with regulations and maintains product quality standards.

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies